Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RC-1291 in cancer anorexia/cachexia
NCT00378131Phase 2Completed
- Start
- Sep 2006
- Primary completion
- Apr 2007
- Modality
- IgG Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of adrecizumab in cancer cachexia. Started Sep 2006; status: completed.
02
Drugs
adrecizumab
03
Conditions
cancer cachexia
Beyond the preview
Go deeper on NCT00378131.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00378131.